Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?

To: The Dodgy Ticker who wrote (64)	1/1/2007 8:27:24 PM
From: tuck	Read Replies (1) \| Respond to of 397

But with AMRI I would look at the profile (I did so for all the ones I flagged). They definitely work on contract drug discovery services, supply some reagents, and I seem to remember AMRI having a royalty interest in an approved drug. Closer than the device companies, IMO. I think the lesson is to look at the profile, and not trust some oddball categorization by a financial info supplier. I think you could leave AMRI in, if you prefer them to ONXX. Cheers, Tuck